Small molecule
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
69
NCT04855435
Safety and Preliminary Efficacy of MBS8(1V270) in Cancer Patients With Advanced Solid Tumours
Phase: Phase 1
Role: Lead Sponsor
Start: Apr 12, 2021
Completion: Jun 30, 2026
Loading map...